Unapproved Qualaquin Use Is Risky
Links shared publicly online about this topic.
- 1,024total visits
Unapproved Qualaquin Use Is Risky
View full resource at webmd.com
Most Recently Shared on July 13, 2010 at 9:42 pm By:
Unapproved Qualaquin Use Is Risky: The FDA has issued a new warning about the use of the malaria drug Qualaquin (q... http://bit.ly/9KmoDo
Also Shared By:
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com
nytimes.com — “A $10,000-per-dose drug is being used in cases in which it was not rigorously tested 97 percent of the time, new studies show.” View full resource at nytimes.com
Most Recently Shared on April 20, 2011 at 1:27 pm By:
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com: http://me.lt/4C1uI
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com
nytimes.com — “A $10,000-per-dose drug is being used in cases in which it was not rigorously tested 97 percent of the time, new studies show.” View full resource at nytimes.com
Most Recently Shared on April 19, 2011 at 9:05 pm By:
Susan Krauss Whitbourne Doctor, Psychologist, and PhD
Another reason to fear #pharma. The dangers of off-label use of prescription #drugs: http://ow.ly/4DGen #health #medicine
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com
nytimes.com — “A $10,000-per-dose drug is being used in cases in which it was not rigorously tested 97 percent of the time, new studies show.” View full resource at nytimes.com
Most Recently Shared on April 19, 2011 at 5:41 pm By:
G Garcia-Manero Doctor, Internist, Oncologist, and Physician
Factor VIIa use outside indication should be questioned http://www.nytimes.com/2011/04/19/health/19surgery.html?hpw
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com
nytimes.com — “A $10,000-per-dose drug is being used in cases in which it was not rigorously tested 97 percent of the time, new studies show.” View full resource at nytimes.com
Most Recently Shared on April 19, 2011 at 12:45 am By:
Hisham Rana, MD Doctor and Physician
Study: Factor VIIa, clotting drug, seen as risky for unapproved uses (Annals of Internal Medicine) http://nyti.ms/h0TNtD - #health
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com
nytimes.com — “A $10,000-per-dose drug is being used in cases in which it was not rigorously tested 97 percent of the time, new studies show.” View full resource at nytimes.com
Most Recently Shared on April 18, 2011 at 10:37 pm By:
Infusion Nurse Nurse and Advanced Practice Nurse
Drug That Stops Bleeding Shows Off-Label Dangers>>>http://nyti.ms/iezoEk #nurses #nursing #IVchat
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com
nytimes.com — “A $10,000-per-dose drug is being used in cases in which it was not rigorously tested 97 percent of the time, new studies show.” View full resource at nytimes.com
Most Recently Shared on April 18, 2011 at 9:32 pm By:
Drug That Stops Bleeding Shows Off-Label Dangers http://nyti.ms/dHbs6E
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com
nytimes.com — “A $10,000-per-dose drug is being used in cases in which it was not rigorously tested 97 percent of the time, new studies show.” View full resource at nytimes.com
Most Recently Shared on April 18, 2011 at 9:27 pm By:
NYT: Drug That Stops Bleeding Shows Off-Label Dangers http://nyti.ms/f9iocF
Factor VIIa, Clotting Drug, Seen as Risky for Unapproved Uses - NYTimes.com
nytimes.com — “A $10,000-per-dose drug is being used in cases in which it was not rigorously tested 97 percent of the time, new studies show.” View full resource at nytimes.com
Most Recently Shared on April 18, 2011 at 8:51 pm By:
NYTimes Science Science Enthusiast
Drug That Stops Bleeding Shows Off-Label Dangers http://nyti.ms/flQJLp
FDA Warns of Risks with Unapproved Use of Malaria Drug Qualaquin
fda.gov — “The U.S. Food and Drug Administration today warned that the unapproved use of the malaria drug Qualaquin (quinine sulfate) to treat night time leg cramps has resulted in serious side effects and prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks.” View full resource at fda.gov
Most Recently Shared on July 12, 2010 at 4:49 pm By:
Infusion Nurse Nurse and Advanced Practice Nurse
FDA Warns of Risks with Unapproved Use of Malaria Drug Qualaquin: http://bit.ly/cbhs79 via @addthis
Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation -- WASHINGTON, March 11 /PRNewswire/ --
prnewswire.com — “Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for Atrial Fibrillation. Physicians and Hospitals Get Kickbacks and Other Incentives Manufacturers Promoting Off-Label, Unapproved Cardiac Surgery Using Their Devices.” View full resource at prnewswire.com
Most Recently Shared on March 24, 2010 at 11:36 am By:
Whistleblower Alerts Americans to Dangers of Risky Unapproved Treatment for A Fibrillation (Cardiac Ablation) http://tinyurl.com/ybo57ml
Advertisement
Heart Health
@HeartsHealth
webMD: Unapproved Qualaquin Use Is Risky http://bit.ly/ar3kuK Full http://bit.ly/dufSdW
1 year ago...